Daily Record, The (Baltimore) - Germantown-based MiddleBrook Pharmaceuticals cuts loss
MiddleBrook Pharmaceuticals Inc., of Germantown, formerly Advancis Pharmaceutical Corp., which develops novel anti-infective products, reported a second-quarter net loss of $9.5 million, or 21 cents per diluted share, on revenue of $2.7 million, versus a net loss of $10.7 million, or 35 cents per share, on revenue of $336,000 in the corresponding 2006 quarter.
Related Results
Germantown-based Advancis Pharmaceutical Corp. pegs higher profits
Advancis Pharmaceutical Corp. of Rockville reports second-quarter
Govt. loses $553K in med-mal suit
Germantown-based MiddleBrook Pharmaceuticals cuts loss
Lilly bets in new drugs.
MiddleBrook attributed the nearly nine-fold increase in revenue to strong sales of its antibiotic Keflex, which it launched in 750-milligram strength capsules during the second half of 2006.
Copyright 2007 Dolan Media Newswires
Provided by ProQuest Information and Learning Company. All rights Reserved.
